1. Home
  2. EVO vs CGBD Comparison

EVO vs CGBD Comparison

Compare EVO & CGBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.76

Market Cap

895.8M

Sector

Health Care

ML Signal

HOLD

Logo Carlyle Secured Lending Inc.

CGBD

Carlyle Secured Lending Inc.

HOLD

Current Price

$11.20

Market Cap

759.8M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVO
CGBD
Founded
1993
2012
Country
Germany
United States
Employees
4766
2500
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
895.8M
759.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
EVO
CGBD
Price
$2.76
$11.20
Analyst Decision
Strong Buy
Hold
Analyst Count
1
8
Target Price
$7.00
$12.92
AVG Volume (30 Days)
106.1K
751.6K
Earning Date
04-08-2026
05-05-2026
Dividend Yield
N/A
15.04%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$3.74
Revenue Next Year
$0.21
$1.80
P/E Ratio
N/A
$10.36
Revenue Growth
N/A
N/A
52 Week Low
$2.31
$10.64
52 Week High
$4.80
$15.15

Technical Indicators

Market Signals
Indicator
EVO
CGBD
Relative Strength Index (RSI) 53.62 49.37
Support Level $2.32 $10.64
Resistance Level $3.75 $11.44
Average True Range (ATR) 0.08 0.29
MACD 0.07 0.03
Stochastic Oscillator 89.69 59.28

Price Performance

Historical Comparison
EVO
CGBD

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About CGBD Carlyle Secured Lending Inc.

Carlyle Secured Lending Inc is a specialty finance company that is a closed-end, externally managed, non-diversified management investment company. It focuses on providing directly originated, financing solutions across the capital structure, with a focus on senior secured lending to middle-market companies located in the United States. The company's investment objective is to generate current income and capital appreciation through debt investments in U.S. middle-market companies.

Share on Social Networks: